BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29931049)

  • 1. Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning.
    Liu Y; Paterson M; Baumgardt SL; Irwin MG; Xia Z; Bosnjak ZJ; Ge ZD
    Cardiovasc Res; 2019 Jan; 115(1):168-178. PubMed ID: 29931049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes.
    Goetzenich A; Hatam N; Preuss S; Moza A; Bleilevens C; Roehl AB; Autschbach R; Bernhagen J; Stoppe C
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):321-8. PubMed ID: 24351506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection.
    Leucker TM; Bienengraeber M; Muravyeva M; Baotic I; Weihrauch D; Brzezinska AK; Warltier DC; Kersten JR; Pratt PF
    J Mol Cell Cardiol; 2011 Nov; 51(5):803-11. PubMed ID: 21791217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.
    Baotic I; Ge ZD; Sedlic F; Coon A; Weihrauch D; Warltier DC; Kersten JR
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H219-27. PubMed ID: 23666677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats.
    Wang C; Weihrauch D; Schwabe DA; Bienengraeber M; Warltier DC; Kersten JR; Pratt PF; Pagel PS
    Anesth Analg; 2006 Aug; 103(2):281-8, table of contents. PubMed ID: 16861403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning.
    Amour J; Brzezinska AK; Weihrauch D; Billstrom AR; Zielonka J; Krolikowski JG; Bienengraeber MW; Warltier DC; Pratt PF; Kersten JR
    Anesthesiology; 2009 Feb; 110(2):317-25. PubMed ID: 19194158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
    Chen G; Xu C; Gillette TG; Huang T; Huang P; Li Q; Li X; Li Q; Ning Y; Tang R; Huang C; Xiong Y; Tian X; Xu J; Xu J; Chang L; Wei C; Jin C; Hill JA; Yang Y
    Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245
    [No Abstract]   [Full Text] [Related]  

  • 9. Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury.
    Bai J; Wang Q; Qi J; Yu H; Wang C; Wang X; Ren Y; Yang F
    Phytomedicine; 2019 Oct; 63():153035. PubMed ID: 31377586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.
    Vladic N; Ge ZD; Leucker T; Brzezinska AK; Du JH; Shi Y; Warltier DC; Pratt PF; Kersten JR
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2130-9. PubMed ID: 21908789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium.
    Chiari PC; Bienengraeber MW; Weihrauch D; Krolikowski JG; Kersten JR; Warltier DC; Pagel PS
    Anesthesiology; 2005 Jul; 103(1):74-83. PubMed ID: 15983459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury.
    Leucker TM; Ge ZD; Procknow J; Liu Y; Shi Y; Bienengraeber M; Warltier DC; Kersten JR
    PLoS One; 2013; 8(7):e70088. PubMed ID: 23894596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway.
    Qiao S; Olson JM; Paterson M; Yan Y; Zaja I; Liu Y; Riess ML; Kersten JR; Liang M; Warltier DC; Bosnjak ZJ; Ge ZD
    Anesthesiology; 2015 Oct; 123(4):786-798. PubMed ID: 26259139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo.
    Krolikowski JG; Weihrauch D; Bienengraeber M; Kersten JR; Warltier DC; Pagel PS
    Can J Anaesth; 2006 Feb; 53(2):174-82. PubMed ID: 16434759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myocyte-protective effect of microRNA-22 during ischemia and reperfusion through disrupting the caveolin-3/eNOS signaling.
    Chen Z; Qi Y; Gao C
    Int J Clin Exp Pathol; 2015; 8(5):4614-26. PubMed ID: 26191152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I.
    Ge ZD; Li Y; Qiao S; Bai X; Warltier DC; Kersten JR; Bosnjak ZJ; Liang M
    Anesthesiology; 2018 Jan; 128(1):117-129. PubMed ID: 29040168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1 modulates the expression of vascular endothelial growth factor and endothelial nitric oxide synthase induced by eccentric exercise.
    Rodriguez-Miguelez P; Lima-Cabello E; Martínez-Flórez S; Almar M; Cuevas MJ; González-Gallego J
    J Appl Physiol (1985); 2015 Apr; 118(8):1075-83. PubMed ID: 25749442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specificity of delayed preconditioning by isoflurane in rabbits: potential role of endothelial nitric oxide synthase.
    Wang C; Chiari PC; Weihrauch D; Krolikowski JG; Warltier DC; Kersten JR; Pratt PF; Pagel PS
    Anesth Analg; 2006 Aug; 103(2):274-80, table of contents. PubMed ID: 16861402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
    Kamel NM; Abd El Fattah MA; El-Abhar HS; Abdallah DM
    Eur J Pharmacol; 2019 Oct; 861():172620. PubMed ID: 31437429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.